| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Acumen Pharmaceuticals, Inc.
13G
ABOS · 00509G209
|
5.0% |
4/7/2026
Event 4/4/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.